Ticker Details
Innovus Pharmaceuticals Inc
IPO Date:	March 4, 2021
Sector:	Healthcare
Industry:	Medical Care Facilities
Market Cap:	$1.11B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 3.16%
Avg Daily Range (30 D):	$0.25 | 3.64%
Avg Daily Range (90 D):	$0.23 | 3.97%

Institutional Daily Volume
Avg Daily Volume:	.14M
Avg Daily Volume (30 D):	.27M
Avg Daily Volume (90 D):	.19M

Trade Size
Avg Trade Size (Sh.):	102
Avg Trade Size (Sh.) (30 D):	75
Avg Trade Size (Sh.) (90 D):	78

Institutional Trades
Total Institutional Trades:	117
Avg Institutional Trade:	$2.6M
Avg Institutional Trade (30 D):	$.67M
Avg Institutional Trade (90 D):	$.67M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.86M
Avg Closing Trade (30 D):	$.67M
Avg Closing Trade (90 D):	$.67M
Avg Closing Volume:	246.33K

News

Dec 11, 2025 @ 9:43 PM Court Approves $27M Cash Settlement in InnovAge Se... Source: Cohen Milstein Sellers & Toll Pllc

Sep 9, 2025 @ 11:19 PM InnovAge Revenue Jumps 11% in Fiscal Q4 Source: Motley Fool Markets Team

Jul 21, 2025 @ 1:00 PM Cohen Milstein Sellers & Toll PLLC Announces Propo... Source: Cohen Milstein Sellers & Toll Pllc

Aug 22, 2024 @ 7:20 PM CORRECTION -- InnovAge PACE Celebrates Anniversary... Source: Clear® Verified

Jun 10, 2024 @ 12:00 PM InnovAge Holding Corp. Announces $5.0 Million Shar... Source: InnovAge

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$.06	$.08	$.06
Diluted EPS	$.06	$.08	$.06
Revenue	$915.37M	$239.71M	$236.11M
Gross Profit	$186.22M	$52.83M	$51.36M
Net Income / Loss	$3.33M	$11.81M	$7.67M
Operating Income / Loss	$9.24M	$13.26M	$8.29M
Cost of Revenue	$292.23M	$74.88M	$75.89M
Net Cash Flow	$38.26M	$16.06M	$3.1M
PE Ratio	148.33

Splits
Mar 18, 2019	1:105